期刊文献+

乙肝重症化的免疫机制

下载PDF
导出
摘要 乙型肝炎重症化过程中,细胞免疫和体液免疫及细胞因子在其中发挥着重要作用。细胞免疫中的CTL,体液免疫中IL-10,IFN-γ。
出处 《中国中医药咨讯》 2011年第3期293-293,共1页
关键词 IL-10 IL-18
  • 相关文献

参考文献5

  • 1Waterhouse NJ, Sutton VR, Sedelies KA, et al. Cytotoxic Tlymphocyte- induced killing in the absence of granzymes Aand B is unique and distinct from both apoptosis and perforin-dependent lysis[J]. J Cell Biol, 2006,173(1):133- 144.
  • 2Leifeld L, Nattermann J, Fielenbach M, et al. Intrahepatic acfivationof caspases in human fulminant hepatic failure [J]. Liver Int,2006,26(7): 872- 879.
  • 3曾俊涛,刘正稳,韩群英,张妮.白细胞介素-10启动区基因多态性与慢性丙型肝炎的相关性[J].西安交通大学学报(医学版),2005,26(1):37-39. 被引量:8
  • 4DU J, LIANG X, LIU Y, et al. Hepatitis B virus core protein inhibit s TRAIL-induced apoptosis of hepatocytes by blocking DR5 [J] . Cell Deat h Differ ,2009,16 (2) :219-229.
  • 5韦叶生,蓝艳,袁锡华,唐任光,黄重敏,王春芳.白细胞介素-2基因多态性与慢性乙型肝炎的相关性[J].中华肝脏病杂志,2008,16(12):889-892. 被引量:3

二级参考文献18

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Sun J, Gao Y, Chen HS, et al. Transfusion of multi-factors activated immtme cells as a novel treatment for patients with chronic hepatitis B. J Clin Virol, 2006, 35: 26-32.
  • 3Nguyen CL, Salem ML, Rubinstein MP, et al. Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2). Vaccine, 2003, 21: 2318-2328.
  • 4Ribeiro CS, Visentainer JE, Moliterno RA. Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem Inst Oswaldo Cruz, 2007, 102: 435-440.
  • 5Chichester JA, Feitelson MA, Calkins CE. Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells. Immunology, 2006, 118: 438-448.
  • 6Jiang R, Feng X, Guo Y, et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J (Engl), 2002, 115: 422-424.
  • 7Hadziyannis SJ. New developments in the treatment of chronic hepatitis B. Expert Opin Biol Ther, 2006, 6:913-921.
  • 8Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1cell [J]. J Immunol, 1991,146(10) :3444-3451.
  • 9Edwards-Smith CJ, Jonsson JR, Purdie DM, et al. Interleukin10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa [J]. Hepatology, 1999, 30(2) :526-530.
  • 10Roh JW, Kim MH, Seo SS, et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women [J].Cancer Lett, 2002, 184(1) :57-63.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部